IIM
INTECH Investment Management Portfolio holdings
AUM
$10.7B
1-Year Return
23.47%
This Quarter Return
+15.26%
1 Year Return
+23.47%
3 Year Return
+97.82%
5 Year Return
–
10 Year Return
–
AUM
$10.7B
AUM Growth
+$949M
(+9.8%)
Cap. Flow
-$169M
Cap. Flow
% of AUM
-1.59%
Top 10 Holdings %
Top 10 Hldgs %
26.63%
Holding
2,728
New
207
Increased
842
Reduced
1,314
Closed
281
Top Buys
| 1 |
Targa Resources
TRGP
|
+$35.2M |
| 2 |
General Motors
GM
|
+$29.6M |
| 3 |
CBRE Group
CBRE
|
+$28.1M |
| 4 |
FedEx
FDX
|
+$27.3M |
| 5 |
Booking.com
BKNG
|
+$24M |
Top Sells
| 1 |
Merck
MRK
|
+$37.9M |
| 2 |
DexCom
DXCM
|
+$36M |
| 3 |
Iron Mountain
IRM
|
+$32.1M |
| 4 |
Walt Disney
DIS
|
+$23.1M |
| 5 |
Hewlett Packard
HPE
|
+$22M |
Sector Composition
| 1 | Technology | 28.62% |
| 2 | Financials | 13.47% |
| 3 | Consumer Discretionary | 12.32% |
| 4 | Healthcare | 10.38% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Bowman Consulting
BWMN
$715M
| $237K | ﹤0.01% |
+8,251
| New | +$237K |
|
2002
Evolus
EOLS
$476M
| $237K | ﹤0.01% |
25,687
-4,117
| -14% | -$37.9K |
|
2003
Red Violet
RDVT
$680M
| $236K | ﹤0.01% |
+4,802
| New | +$236K |
|
2004
MACOM Technology Solutions
MTSI
$9.73B
| $236K | ﹤0.01% |
+1,648
| New | +$236K |
|
2005
Trevi Therapeutics
TRVI
$1.17B
| $235K | ﹤0.01% |
43,009
+20,994
| +95% | +$115K |
|
2006
Arbutus Biopharma
ABUS
$968M
| $234K | ﹤0.01% |
75,849
| – | – |
|
2007
Nordic American Tanker
NAT
$682M
| $234K | ﹤0.01% |
88,948
-13,645
| -13% | -$35.9K |
|
2008
Bandwidth Inc
BAND
$487M
| $234K | ﹤0.01% |
14,709
+449
| +3% | +$7.14K |
|
2009
Tango Therapeutics
TNGX
$744M
| $234K | ﹤0.01% |
45,675
+5,518
| +14% | +$28.3K |
|
|
UPB
2010
Upstream Bio, Inc. Common Stock
UPB
$960M
| $234K | ﹤0.01% |
21,290
+6,005
| +39% | +$65.9K |
|
2011
Arcturus Therapeutics
ARCT
$488M
| $233K | ﹤0.01% |
17,923
-91
| -0.5% | -$1.18K |
|
2012
Amylyx Pharmaceuticals
AMLX
$1.05B
| $233K | ﹤0.01% |
+36,315
| New | +$233K |
|
2013
Golden Entertainment
GDEN
$645M
| $233K | ﹤0.01% |
7,907
-4,499
| -36% | -$132K |
|
2014
Arhaus
ARHS
$1.58B
| $233K | ﹤0.01% |
26,819
+3,178
| +13% | +$27.6K |
|
2015
Nabors Industries
NBR
$616M
| $232K | ﹤0.01% |
8,286
+2,786
| +51% | +$78.1K |
|
2016
Arvinas
ARVN
$568M
| $232K | ﹤0.01% |
31,528
-14,980
| -32% | -$110K |
|
2017
Peapack-Gladstone Financial
PGC
$512M
| $231K | ﹤0.01% |
8,193
-2,173
| -21% | -$61.4K |
|
2018
Redwire
RDW
$1.23B
| $230K | ﹤0.01% |
14,140
-9,996
| -41% | -$163K |
|
|
JBIO
2019
Jade Biosciences, Inc. Common Stock
JBIO
$257M
| $230K | ﹤0.01% |
+22,995
| New | +$230K |
|
|
TRTX
2020
TPG RE Finance Trust
TRTX
$743M
| $230K | ﹤0.01% |
29,736
-8,388
| -22% | -$64.8K |
|
2021
Aspen Aerogels
ASPN
$535M
| $229K | ﹤0.01% |
38,723
+48
| +0.1% | +$284 |
|
2022
Great Southern Bancorp
GSBC
$715M
| $227K | ﹤0.01% |
3,857
-1,630
| -30% | -$95.8K |
|
2023
Repay Holdings
RPAY
$501M
| $227K | ﹤0.01% |
47,029
-11,966
| -20% | -$57.7K |
|
2024
NWPX Infrastructure, Inc. Common Stock
NWPX
$505M
| $227K | ﹤0.01% |
+5,527
| New | +$227K |
|
|
ATYR
2025
aTyr Pharma
ATYR
$517M
| $226K | ﹤0.01% |
+44,668
| New | +$226K |
|